Toxicogenomics in drug safety assessment

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.9, Iss.4, 2008-04, pp. : 379-382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Toxicogenomics: an opportunity to optimise drug development and safety evaluation

By Kolaja Kyle L Kramer Jeffrey A

Expert Opinion on Drug Safety, Vol. 1, Iss. 3, 2002-09 ,pp. : 275-286

Informa Healthcare

Access to resources Recommend Favorite

Future of toxicogenomics and safety signatures: balancing public access to data with proprietary drug discovery

By Fostel Jennifer M

Pharmacogenomics, Vol. 8, Iss. 5, 2007-05 ,pp. : 425-430

Future Medicine

Access to resources Recommend Favorite

Zebrafish Model in Drug Safety Assessment

Current Pharmaceutical Design, Vol. 20, Iss. 34, 2014-10 ,pp. : 5416-5429

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicogenomics strategies for predicting drug toxicity

By Martin Rory Rose David Yu Kai Barros Scott

Pharmacogenomics, Vol. 7, Iss. 7, 2006-10 ,pp. : 1003-1016

Future Medicine

Access to resources Recommend Favorite

Toxicogenomics

Current Drug Metabolism, Vol. 9, Iss. 3, 2008-03 ,pp. : 250-254

Bentham Science Publishers

Access to resources Recommend Favorite